Investigation No. 001
The Turmeric Problem
Over a hundred trials, and still no clean answer
Turmeric is the best-selling botanical supplement in the United States and one of the most heavily studied compounds in medicine. Neither of those facts tells you whether it works. This episode follows curcumin from the spice rack to the pharmacokinetics, through the one trial people actually cite, and into a liver-injury case series nobody puts on the label.
The investigation
- The claim
- “Turmeric is a natural anti-inflammatory — as effective as ibuprofen, without the side effects.”
- The evidence
Curcumin makes up only a few per cent of turmeric, and it is very poorly absorbed. A widely cited review of its pharmacokinetics attributes the low plasma and tissue levels to poor absorption, rapid metabolism and rapid systemic elimination — while noting the compound appears safe even at 12 g a day.
The standard fix is piperine, the active compound in black pepper, which interferes with glucuronidation. In a small 1998 human study, 20 mg of piperine raised curcumin bioavailability by about 2,000%. That single result is the reason almost every commercial turmeric capsule now contains black pepper.
In 2017 a medicinal-chemistry review classified curcumin as both a PAINS (pan-assay interference) and an IMPS (invalid metabolic panacea) candidate — a molecule that reliably produces false positives in laboratory assays — and reported that across more than 120 clinical trials of curcuminoids, no double-blind, placebo-controlled trial had succeeded.
The strongest clinical signal is a 367-patient multicentre trial in knee osteoarthritis, in which turmeric extract at 1,500 mg a day was non-inferior to 1,200 mg of ibuprofen over four weeks, with fewer reports of abdominal pain. It ran for four weeks and had no placebo arm.
The US Drug-Induced Liver Injury Network has reported ten adjudicated cases of turmeric-associated liver injury, all enrolled since 2011 and six since 2017. Five patients were hospitalised and one died of acute liver failure. Seven of the ten carried HLA-B*35:01. Three of the seven products chemically analysed also contained piperine.
Curcumin is a biologically active iron chelator, and that is not a theoretical concern. In mice it produced a dose-dependent fall in haematocrit, haemoglobin, serum iron and transferrin saturation, microcytic red cells, and it suppressed hepcidin — the hormone that governs how much iron the body lets in. The authors warned explicitly about use in patients with marginal iron stores. A later colitis model found curcumin induced anaemia even on an iron-SUFFICIENT diet, and worsened the colitis it was given to treat.
- The verdict
- Not proven — and not harmlessThe osteoarthritis signal is real enough to take seriously and far too thin to call settled: four weeks against an active comparator, with no placebo arm, is not a win. Two harms are better established than the benefit. The additive that makes the supplement absorbable at all is the same one turning up in the liver-injury series, and curcumin is an iron chelator that suppresses hepcidin — which puts menstruating women, vegetarians and anyone with low ferritin squarely in its path. If you take turmeric, take it for a stated reason, for a defined period, with a ferritin before and after, and tell whoever manages your medications.
- Change our mind
- A double-blind, placebo-controlled trial running six months or longer, with a pre-registered primary endpoint and a bioavailability-enhanced formulation at a disclosed dose.
Show notes
Turmeric sits in an strange position. It is simultaneously the best-selling botanical supplement in the country, one of the most-published compounds in the biomedical literature, and a molecule that a serious medicinal-chemistry review argued should never have become a drug-development target at all.
Both things are true at once, and the gap between them is where the money lives.
So we go in the order the evidence appears: what curcumin is, what your body does to it, why black pepper ended up in the capsule, what the trials measured, and what turned up in the safety reporting afterwards. Leaving no leaf unturned — including the ones nobody wants turned.
Nothing here says turmeric does nothing. This says the confident version of the claim — as good as ibuprofen, no downside — is not what the literature says. And you deserve to know the difference.
The part that is almost never said out loud. Turmeric's risk gets discussed as a liver question. It is also an iron question, and that one matters more, because it lands on the people most likely to be taking it. Curcumin binds iron — that is a chemical property of the molecule, not a contaminant or a dose problem — and it lowers hepcidin, so the body absorbs less and stores less. Hepcidin is the hormone your liver uses to decide how much iron to let through the gut wall; push it down and you quietly run the tap backwards.
Who that lands on: menstruating women, anyone with heavy periods, vegetarians and vegans, people with coeliac disease or inflammatory bowel disease, blood donors, people already on the edge of low ferritin, and patients with the anaemia of chronic disease. That is a very large fraction of the people who buy turmeric for joint pain. If you are one of them and you take it daily, a ferritin and a full blood count are not paranoia, they are the minimum. And if you are taking iron and turmeric together, do not take them in the same hour.
None of this makes turmeric a bad molecule. It makes it a pharmacologically active one, which is what we claim to want from it. You do not get to call something a natural anti-inflammatory and then be surprised that it also does something else.
Sources
Every paper referenced on air, in the order it comes up. Links go to the publisher via DOI.
- Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The Essential Medicinal Chemistry of Curcumin.J Med Chem · 2017 · 60(5):1620–1637
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises.Mol Pharm · 2007 · 4(6):807–818
- Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.Planta Med · 1998 · 64(4):353–356
- Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study.Clin Interv Aging · 2014 · 9:451–458
- Halegoua-DeMarzio D, Navarro V, Ahmad J, et al. Liver Injury Associated with Turmeric — A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network (DILIN).Am J Med · 2023 · 136(2):200–206
- Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M. Curcumin and Health.Molecules · 2016 · 21(3):264
- Jiao Y, Wilkinson J, Di X, et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.Blood · 2009 · 113(2):462–469
- Samba-Mondonga M, Constante M, Fragoso G, Calvé A, Santos MM. Curcumin induces mild anemia in a DSS-induced colitis mouse model maintained on an iron-sufficient diet.PLoS One · 2019 · 14(4):e0208677
- Halegoua-DeMarzio D, Navarro V. Challenges in herbal-induced liver injury identification and prevention.Liver Int · 2025 · 45(3):e16071
This is education, not medical advice. Nothing in this episode is written with knowledge of your history, your medications or your risks. Do not start or stop any treatment on the basis of it — talk to your own physician. Read the full medical disclaimer.